012790 — Sinil Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual cashflow statement for Sinil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7,257	7,544	6,679	12,157	13,641
Depreciation
Amortisation
Non-Cash Items	2,698	2,424	3,047	4,064	3,589
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1,930	-3,339	-3,099	-6,965	-7,437
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	12,306	11,062	11,163	13,688	15,154
Capital Expenditures	-7,248	-8,471	-3,629	-9,329	-12,921
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,620	-138	-3,036	-5,551	1,601
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-9,868	-8,609	-6,665	-14,880	-11,319
Financing Cash Flow Items	—	—	—	—	92
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,188	-1,255	-1,347	-1,319	-1,248
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,248	1,188	3,176	-2,396	2,576